Preferred method of communication
Research and teaching
- Malignant Hematology
- CLL and Hematopoietic Stem Cell Transplantation
Summary of Research
Principal investigator for the GEMHDM2014 study, an investigator-initated phase I/II trial using infusional gemcitabine in combination with high dose melphalan in patients with relapsed lymphoma. Active in multiple clinical trials with novel agents as Sub-Investigator for patients with indolent and aggressive lymphoma, and chronic lymphocytic leukemia.
Dr. Mona Shafey is a Clinical Associate Professor in the Division of Hematology and Hematological Malignancies and Medical Director of the Alberta Blood & Marrow Transplant Program. She completed medical school and residency training at the University of Ottawa in 2008 and completed fellowship training in Hematopoietic Stem Cell Transplantation at the University of Calgary in 2010. Her clinical and research interests are in malignant hematology with a focus on the management of patients with lymphoma and CLL, including the use of cellular therapies (stem cell transplantation and CAR T-cell therapies) in the treatment of these diseases.